tcsc0139 SB 216763

Order Now

AVAILABLE SIZES

$86.00 ORDERING INFORMATION International
TAICLONE BIOTECH CORP.
order@taiclone.com
+886-2-2735-9682
+886-2-2735-9807

Data sheet

Download PDF Datasheet

Technical Inquries

Submit Review

Product Description

SB 216763 is potent and selective and ATP-competitive glycogen synthase kinase-3 (GSK-3) inhibitor, with an IC50 value of 34.3 nM for GSK-3α and GSK-3β, respectively.

IC50 & Target: IC50: 34.3 nM (GSK-3α), 34.3 nM (GSK-3β)[5]

In Vitro: SB-216763 (10-20 µM) induces β-catenin mediated-transcription in a dose-dependent manner in HEK293 cells. SB-216763 (10, 15 and 20 µM) can maintain mESCs with a pluripotent-like morphology in long-term culture. SB-216763 (10 µM) can maintain J1 mESCs in a pluripotent state for more than a month[2]. SB-216763 inhibits GSK-3 with IC50 of 34 nM[3]. SB-216763 is equally effective at inhibiting human GSK-3α and GSK-3β[5].

In Vivo: SB216763 (20 mg/kg, i.v.) significantly improves the survival of BLM-treated mice. Mice randomized to receive BLM plus SB216763 shows a noteworthy reduction, compared with BLM-treated mice. SB216763 (20 mg/kg, i.v.) reduces the magnitude of BLM-induced alveolitis[1]. SB 216763 (0.2 mg/kg, i.v.) with either 17β-E100 or Geni100 reverses the ceiling effect because these agents significantly reduce infarct size when the rabbits' hearts are submitted to 30-min CAO[4].

Information

CAS No280744-09-4
FormulaC19H12Cl2N2O2
Clinical Informationclinicalinformation
PathwayStem Cell/Wnt
PI3K/Akt/mTOR
Autophagy
TargetGSK-3
GSK-3
Autophagy

Specifications

Purity / Grade>98%
SolubilityH2O : < 0.1 mg/mL (insoluble)
Smilessmiles

Misc Information

Observed Molecular Weight371.22
Get valuable resources and offers directly to your email.